Ning Lou
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Renal and related cancers
- Epigenetics and DNA Methylation
Papers in
-
- Epigenetics and DNA Methylation 3
- Ubiquitin and proteasome pathways 2
- Renal and related cancers 2
-
- Ferroptosis and cancer prognosis 2
- Renal cell carcinoma treatment 2
- Co-authors
- Xiaoping Zhang (13 shared papers)Hongmei Yang (11 shared papers)Hailong Ruan (9 shared papers)Wenjun Hu (6 shared papers)Bin Qiu (7 shared papers)Yali Zhou (4 shared papers)Weiwei Han (5 shared papers)Ke Chen (5 shared papers)
- Journals
- Cellular Signalling (2 papers)Oncology Reports (2 papers)Tumor Biology (2 papers)European Journal of Immunology (1 paper)Molecular Immunology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Ning Lou
36 papers receiving 652 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 245
- Molecular Biology 348
- Oncology 105
- Pulmonary and Respiratory Medicine 120
- Immunology 65
Countries citing papers authored by Ning Lou
This map shows the geographic impact of Ning Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Lou more than expected).
Fields of papers citing papers by Ning Lou
This network shows the impact of papers produced by Ning Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Lou. The network helps show where Ning Lou may publish in the future.
Co-authors
The 25 scholars most cited alongside Ning Lou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 82 | |
| 2 | 2014 | 67 | |
| 3 | 2016 | 46 | |
| 4 | 2018 | 45 | |
| 5 | 2016 | 38 | |
| 6 | 2017 | 37 | |
| 7 | 2016 | 34 | |
| 8 | 2017 | 29 | |
| 9 | 2020 | 24 | |
| 10 | 2023 | 23 | |
| 11 | 2016 | 21 | |
| 12 | Expression of CXCL12/CXCR4 and its correlation to prognosis in esophageal squamous cell carcinoma. | 2009 | 20 |
| 13 | 2018 | 19 | |
| 14 | 2005 | 18 | |
| 15 | 2014 | 17 | |
| 16 | 2016 | 16 | |
| 17 | 2022 | 15 | |
| 18 | 2020 | 15 | |
| 19 | 2017 | 13 | |
| 20 | 2013 | 13 |
About Ning Lou
Ning Lou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Immunology, having authored 37 papers that have together received 657 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (3 papers), Chemokine receptors and signaling (3 papers), Cancer-related molecular mechanisms research (3 papers), Ubiquitin and proteasome pathways (2 papers), Ferroptosis and cancer prognosis (2 papers), Renal cell carcinoma treatment (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and Renal and related cancers (2 papers). The work is most often cited by research in Cancer Research (245 citations), Molecular Biology (348 citations), Oncology (105 citations), Pulmonary and Respiratory Medicine (120 citations) and Immunology (65 citations). Ning Lou has collaborated with scholars based in China and United States. Frequent co-authors include Xiaoping Zhang, Hongmei Yang, Hailong Ruan, Wenjun Hu, Bin Qiu, Yali Zhou, Weiwei Han, Ke Chen, Wen Xiao and Xuanyu Chen. Their work appears in journals such as Cellular Signalling, Oncology Reports, Tumor Biology, European Journal of Immunology and Molecular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.